Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.43
-0.02 (-0.31%)
At close: Dec 5, 2025, 4:00 PM EST
6.43
0.00 (0.00%)
After-hours: Dec 5, 2025, 5:52 PM EST
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $408.33 million as of December 5, 2025. Its market cap has decreased by -10.56% in one year.
Market Cap
408.33M
Enterprise Value
264.21M
1-Year Change
-10.56%
Ranking
Category
Stock Price
$6.43
Market Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has increased from $397.73M to $408.33M, an increase of 2.66%. That is a compound annual growth rate of 0.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 409.60M | -0.24% |
| Dec 31, 2024 | 410.60M | -5.92% |
| Dec 29, 2023 | 436.44M | 12.22% |
| Dec 30, 2022 | 388.92M | -21.59% |
| Dec 31, 2021 | 496.00M | 24.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 906.98B |
| Johnson & Johnson | 486.68B |
| AbbVie | 400.21B |
| UnitedHealth Group | 300.18B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 248.85B |
| Abbott Laboratories | 218.92B |